2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow NCX 1020: new trials by email Literature Review of NCX 1020 trials Research Report on NCX 1020
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients TPI 1020, Budesonide, Placebo - Copd Bronchitis | Phase 2 | Completed | Syntara | 62 | 2007-11-01 | 2012-12-03 |
| Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma TPI-1020, budesonide - Asthma | Phase 2 | Completed | Syntara | 27 | 2006-05-01 | 2012-12-03 |
Asthma (1)
Syntara (2)
Canada (2)
Francois Maltais, MD (1) · Paolo Renzi, MD (1) · Rene Pageau, M.Sc Pharm (1)